1	Aumentar	aumentar	VMN0000	-	-	0-8	98_ANS_clinical_caseMIR	SENT1	-	-
2	la	el	DA0FS0	-	-	9-11	98_ANS_clinical_caseMIR	SENT1	-	-
3	dosis	dosis	NCFN000	-	-	12-17	98_ANS_clinical_caseMIR	SENT1	-	-
4	de	de	SPS00	C0332285	atributo	18-20	98_ANS_clinical_caseMIR	SENT1	-	-
5	corticoides	corticoide	NCMP000	-	-	21-32	98_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
6	inhalados	inhalar	VMP00PM	-	-	33-42	98_ANS_clinical_caseMIR	SENT1	-	-
7	a	a	SPS00	-	-	43-44	98_ANS_clinical_caseMIR	SENT1	-	-
8	800	800		-	-	45-48	98_ANS_clinical_caseMIR	SENT1	-	-
9	microgramos	microgramo	NCMP000	C0439211	calificador	49-60	98_ANS_clinical_caseMIR	SENT1	-	-
10	/	/	Fh	-	-	60-61	98_ANS_clinical_caseMIR	SENT1	-	-
11	día	día	NCMS000	C0439228#C0332169	calificador	61-64	98_ANS_clinical_caseMIR	SENT1	-	-
12	.	.	Fp	-	-	64-65	98_ANS_clinical_caseMIR	SENT1	-	-

1	Añadir	añadir	VMN0000	-	-	0-6	98_ANS_clinical_caseMIR	SENT2	-	-
2	tiotropio	tiotropio	NC00SC0	C0213771	producto#sustancia	7-16	98_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
3	.	.	Fp	-	-	16-17	98_ANS_clinical_caseMIR	SENT2	-	-

1	Mantener	mantener	VMN0000	-	-	0-8	98_ANS_clinical_caseMIR	SENT3	-	-
2	la	el	DA0FS0	-	-	9-11	98_ANS_clinical_caseMIR	SENT3	-	-
3	misma	mismo	AQ0FS0	C0445247	calificador	12-17	98_ANS_clinical_caseMIR	SENT3	-	-
4	pauta	pauta	NCFS000	-	-	18-23	98_ANS_clinical_caseMIR	SENT3	-	-
5	farmacológica	farmacológico	AQ0FS0	C0205464	calificador	24-37	98_ANS_clinical_caseMIR	SENT3	-	-
6	.	.	Fp	-	-	37-38	98_ANS_clinical_caseMIR	SENT3	-	-

1	Cambiar	cambiar	VMN0000	-	-	0-7	98_ANS_clinical_caseMIR	SENT4	-	-
2	a	a	SPS00	-	-	8-9	98_ANS_clinical_caseMIR	SENT4	-	-
3	una	una		C0205447_1	calificador_1	10-13	98_ANS_clinical_caseMIR	SENT4	-	-
4	terapia	terapia	NCFS000	C0033972_1	procedimiento_1	14-21	98_ANS_clinical_caseMIR	SENT4	-	-
5	combinada	combinar	VMP00SF	C0033972_2	procedimiento_2	22-31	98_ANS_clinical_caseMIR	SENT4	-	-
6	con	con	SPS00	C0332287	atributo	32-35	98_ANS_clinical_caseMIR	SENT4	-	-
7	corticoides	corticoide	NCMP000	-	-	36-47	98_ANS_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
8	inhalados	inhalar	VMP00PM	-	-	48-57	98_ANS_clinical_caseMIR	SENT4	-	-
9	a	a	SPS00	-	-	58-59	98_ANS_clinical_caseMIR	SENT4	-	-
10	dosis	dosis	NCFN000	-	-	60-65	98_ANS_clinical_caseMIR	SENT4	-	-
11	bajas	bajo	AQ0FP0	C0205251	calificador	66-71	98_ANS_clinical_caseMIR	SENT4	-	-
12	y	y	CC	C1706368	calificador	72-73	98_ANS_clinical_caseMIR	SENT4	-	-
13	beta2-adrenérgicos	beta2-adrenérgicos		-	-	74-92	98_ANS_clinical_caseMIR	SENT4	-	-
14	de	de	SPS00	C0332285	atributo	93-95	98_ANS_clinical_caseMIR	SENT4	-	-
15	acción	acción	NCFS000	C0441472#C3266814	calificador#atributo	96-102	98_ANS_clinical_caseMIR	SENT4	-	-
16	prolongada	prolongar	VMP00SF	-	-	103-113	98_ANS_clinical_caseMIR	SENT4	-	-
17	.	.	Fp	-	-	113-114	98_ANS_clinical_caseMIR	SENT4	-	-

1	Añadir	añadir	VMN0000	-	-	0-6	98_ANS_clinical_caseMIR	SENT5	-	-
2	antileucotrienos	antileucotrieno	NCMP000	-	-	7-23	98_ANS_clinical_caseMIR	SENT5	B-Grp_Medicamento	-
3	.	.	Fp	-	-	23-24	98_ANS_clinical_caseMIR	SENT5	-	-

